Back to drug

The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

XII.g

Coronary artery disease (acute) - Myocardial ischemia/infarction

Publications

Celiker M, Tuncer M, Sekeralmaz A

A Case with Repeated Recurrent Acute Coronary Syndrome due to Pseudoephedrine Use: Kounis Syndrome.

Case reports in medicine. 2014;2014:742905

Celik A

ST elevation myocardial infarction presenting after use of pseudoephedrine.

Cardiovascular toxicology. 2009;9(2):103-4

Akay S, Ozdemir M

Acute coronary syndrome presenting after pseudoephedrine use and regression with beta-blocker therapy.

The Canadian journal of cardiology. 2008;24(11):e86-8

Biyik I, Ergene O

Myocardial infarction associated with pseudoephedrine use and acute streptococcal infection in a boy with normal coronary arteries.

The Canadian journal of cardiology. 2006;22(3):254-6

Pederson KJ, Kuntz DH, Garbe GJ

Acute myocardial ischemia associated with ingestion of bupropion and pseudoephedrine in a 21-year-old man.

The Canadian journal of cardiology. 2001;17(5):599-601